Piramal Pharma Ltd (Mumbai)

United Breweries Ltd, Syngene International Ltd, Star Health & Allied Insurance Company Ltd, Cartrade Tech Ltd are among the other stocks to see a surge in volumes on NSE today, 28 October 2026.Piramal Pharma Ltd registered volume of 1056.45 lakh shares by 14:24 IST on NSE, a 44.08 fold spurt over two-week average daily volume of 23.97 lakh shares. The stock rose 17.41% to Rs.233.32. Volumes stood at 28.74 lakh shares in the last session.United Breweries Ltd clocked volume of 42.46 lakh shares by 14:24 IST on NSE, a 26.69 times surge over two-week average daily volume of 1.59 lakh shares. The stock gained 6.30% to Rs.1,215.70. Volumes stood at 76806 shares in the last session.Syngene International Ltd saw volume of 204.77 lakh shares by 14:24 IST on NSE, a 25.98 fold spurt over two-week average daily volume of 7.88 lakh shares. The stock increased 10.61% to Rs.405.05. Volumes stood at 8.87 lakh shares in the last session.Star Health & Allied Insurance Company Ltd clocked volume of 30.46 lakh shares by 14:24 IST on NSE, a 14.67 times surge over two-week average daily volume of 2.08 lakh shares. The stock lost 5.35% to Rs.517.50. Volumes stood at 1.45 lakh shares in the last session.Cartrade Tech Ltd recorded volume of 40.07 lakh shares by 14:24 IST on NSE, a 13.85 times surge over two-week average daily volume of 2.89 lakh shares. The stock lost 9.10% to Rs.2,564.40. Volumes stood at 1.67 lakh shares in the last session.

Piramal Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 232.02, up 16.76% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.19% on the day, quoting at 22705.75. The Sensex is at 73339.6, down 0.35%. Piramal Pharma Ltd has gained around 10.98% in last one month. Meanwhile, Nifty Pharma index of which Piramal Pharma Ltd is a constituent, has gained around 1.54% in last one month and is currently quoting at 26267.25, up 0.96% on the day. The volume in the stock stood at 879.51 lakh shares today, compared to the daily average of 23.06 lakh shares in last one month.The PE of the stock is 34.1 based on TTM earnings ending June 26.

Lumax Auto Technologies Ltd, United Breweries Ltd, PG Electroplast Ltd and Syngene International Ltd are among the other gainers in the BSE's 'A' group today, 28 October 2026.Piramal Pharma Ltd spiked 14.74% to Rs 227.7 at 11:48 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 53.3 lakh shares were traded on the counter so far as against the average daily volumes of 2.81 lakh shares in the past one month. Lumax Auto Technologies Ltd soared 7.28% to Rs 2047.2. The stock was the second biggest gainer in 'A' group. On the BSE, 11127 shares were traded on the counter so far as against the average daily volumes of 17252 shares in the past one month. United Breweries Ltd surged 7.15% to Rs 1225.4. The stock was the third biggest gainer in 'A' group. On the BSE, 7.85 lakh shares were traded on the counter so far as against the average daily volumes of 10209 shares in the past one month. PG Electroplast Ltd added 6.38% to Rs 531.9. The stock was the fourth biggest gainer in 'A' group. On the BSE, 3.92 lakh shares were traded on the counter so far as against the average daily volumes of 1.1 lakh shares in the past one month. Syngene International Ltd gained 6.23% to Rs 388.8. The stock was the fifth biggest gainer in 'A' group. On the BSE, 2.75 lakh shares were traded on the counter so far as against the average daily volumes of 83962 shares in the past one month.

Piramal Pharma Ltd share price gained 1.69% to Rs 198.45 after the company's net profit witnessed a sharp fall of 107.25% to Rs 5.03 crore, while revenue from operations increased 15.29% to Rs 2617.06 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.44 lakh crore, easing 4.06%. It has improved by 3.17% over last one week and eased lower by 0.26% in last one month while the market capitalization of Piramal Pharma Ltd has marginally improved by 3.85% and 0.81% in the same period respectively. Profit before tax (PBT) of Piramal Pharma Ltd stood at Rs 81.63 crore in Q3 FY26, tanking 276.76% year-on-year, and nosediving by 1194.24% quarter-on-quarter. EBITDA came in at Rs 313 crore, surging by 236.03% YoY and jumping 195.69% sequentially. Total expenses posted a minor rise of 8.84% to Rs 2501.47 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 645.82 crore, contracting by 10.89% YoY, while employee benefits expense was at Rs 714.32 crore, inching up 5.73% YoY. For the TTM ended FY26, revenue from operations eased 3.08% to Rs 8869.08 crore, while net profit tumbled by 457.66% to Rs 325.94 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 132392% to Rs 708.32 crore, and PBT collapsed by 142.46% to Rs 176.06 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 1652.6 crore in FY26, as against Rs 892.3 crore in FY25. Piramal Pharma Ltd slipped 2.34% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 13.19% during the same period.

Piramal Pharma Limited will hold a board meeting on Tuesday, 27th October 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended 30th September 2026, according to a regulatory filing. The trading window for the company's securities will remain closed from Thursday, 1st October 2026, until Thursday, 29th October 2026.

Piramal Pharma Limited announced the appointment of Mr. Viral Gandhi as Chief Technology Officer and a Senior Management Personnel, effective October 1, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited on September 30, 2026.

Piramal Pharma Limited announced that Jeffrey Hampton will retire as President and COO of Piramal Critical Care, effective November 27, 2026, and that Brian Guy has been appointed as President and COO of Piramal Critical Care, effective October 19, 2026.

Piramal Pharma Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in securities of the company will be closed for all designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the half year ending September 30, 2026, with the date of the board meeting to approve the results to be communicated later.

Piramal Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 213.73, up 2.68% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.29% on the day, quoting at 23413.6. The Sensex is at 74818.76, up 0.71%. Piramal Pharma Ltd has gained around 1.22% in last one month. Meanwhile, Nifty Pharma index of which Piramal Pharma Ltd is a constituent, has gained around 2.67% in last one month and is currently quoting at 26710.1, up 1.25% on the day. The volume in the stock stood at 24.24 lakh shares today, compared to the daily average of 42.19 lakh shares in last one month.The PE of the stock is 35.74 based on TTM earnings ending June 26.

Piramal Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 202.53, down 0.46% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.65% on the day, quoting at 23269.55. The Sensex is at 74411.94, up 0.55%.Piramal Pharma Ltd has eased around 1.07% in last one month.Meanwhile, Nifty Pharma index of which Piramal Pharma Ltd is a constituent, has eased around 0.81% in last one month and is currently quoting at 26188.4, down 0.23% on the day. The volume in the stock stood at 20.96 lakh shares today, compared to the daily average of 43.66 lakh shares in last one month.The PE of the stock is 34.97 based on TTM earnings ending June 26.